IIM
CSTL icon

INTECH Investment Management’s Castle Biosciences CSTL Stock Holding History

INTECH Investment Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
+8,580
New +$191K ﹤0.01% 1785
2026
Q1 		– Sell
-11,718
Closed -$456K – 2156
2025
Q4 		$456K Sell
11,718
-674
-5% -$21.7K ﹤0.01% 1555
2025
Q3 		$282K Buy
12,392
+103
+0.8% +$2.09K ﹤0.01% 1859
2025
Q2 		$251K Sell
12,289
-3,789
-24% -$70.1K ﹤0.01% 1976
2025
Q1 		$322K Buy
16,078
+4,500
+39% +$111K ﹤0.01% 1849
2024
Q4 		$309K Buy
11,578
+3,294
+40% +$100K ﹤0.01% 1819
2024
Q3 		$236K Buy
+8,284
New +$211K ﹤0.01% 1643

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's CSTL Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Castle Biosciences (CSTL) in Q2 2026: 8,580 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #1785 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in CSTL as recently as Q4 2025.

INTECH Investment Management first reported a position in CSTL in Q3 2024 and has held it in 7 quarters since. The position peaked at $456K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • INTECH Investment Management held 8,580 shares of Castle Biosciences worth $205K as of Q2 2026.
  • Castle Biosciences was a new INTECH Investment Management position in Q2 2026.
  • Castle Biosciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1785 holding.
  • INTECH Investment Management first reported a position in Castle Biosciences in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Castle Biosciences position peaked at $456K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.